Instrument Inactif

Communiqués Alexza Pharmaceuticals, Inc. Nasdaq

Actions

US0153841004

Recherche biotechnologique et médicale

Cours en clôture Nasdaq
- ^USD	-

22/12/15	Alexza Pharmaceuticals : Les valeurs à suivre sur les marchés américains	RE
22/12/15	USA-Les valeurs à suivre à Wall Street	RE

Communiqués

28/03/16	Alexza Pharmaceuticals : Reports Fourth Quarter and Year End 2015 Financial Results	PU
15/03/16	Alexza Pharmaceuticals : to Report 2015 Year End Financial Results and Provide Company Update on Monday, March 28, 2016	PU
09/03/16	Alexza Pharmaceuticals : Receives Positive Nasdaq Listing Determination	PU
27/02/16	Alexza Pharmaceuticals : Confirms Grupo Ferrer Non-binding Letter of Intent	PU
24/02/16	Alexza Pharmaceuticals : Reacquires U.S. Commercial Rights for ADASUVE® (loxapine) inhalation powder	PU
16/12/14	Alexza Pharmaceuticals : Amends Autoliv Agreement for Heat Packages Used in ADASUVE®	PU
11/12/14	Alexza Pharmaceuticals : Diario Medico Names ADASUVE® in its "Best Ideas of 2014"	PU
08/08/14	Alexza Pharmaceuticals : Announces the Launch of ADASUVE® (inhalation powder, loxapine) in Guatemala	PU
13/03/14	Alexza Pharmaceuticals : and Ferrer Announce the Launch of ADASUVE® (inhalation powder, loxapine) in Romania	PU
03/03/14	Alexza Pharmaceuticals, Inc. : Alexza Announces the U.S. Commercial Launch of ADASUVE® by Teva Pharmaceuticals	PU
21/11/13	Alexza Pharmaceuticals, Inc. : Alexza Pharmaceuticals to Present at the 25th Annual Piper Jaffray Healthcare Conference	PU
06/11/13	Alexza Pharmaceuticals, Inc. : Alexza Reports 2013 Third Quarter Financial Results	PU
24/10/13	Alexza Pharmaceuticals, Inc. : Alexza Pharmaceuticals and Grupo Ferrer Announce the Launch of ADASUVE® (Staccato® Loxapine) in Austria	PU
16/10/13	Alexza Pharmaceuticals, Inc. : Alexza to Report 2013 Third Quarter Financial Results on Wednesday, November 6, 2013	PU
29/08/13	Alexza Pharmaceuticals, Inc. : Alexza Pharmaceuticals to Present at the Stifel Healthcare Conference 2013	PU
09/08/13	Alexza Pharmaceuticals, Inc. : Alexza Reports Preliminary 2013 Second Quarter Financial Results	PU
07/08/13	Alexza Pharmaceuticals, Inc. : Alexza Pharmaceuticals to Present at the 2013 Wedbush Life Sciences Management Access Conference	PU
01/08/13	Alexza Pharmaceuticals, Inc. : Alexza Announces Management Promotions	PU
30/07/13	Alexza Pharmaceuticals, Inc. : Alexza Pharmaceuticals Announces European Launch of ADASUVE® (Staccato® Loxapine)	PU
15/07/13	Alexza Pharmaceuticals, Inc. : Alexza to Report 2013 Second Quarter Financial Results on Thursday, August 8, 2013	PU
02/07/13	Alexza Pharmaceuticals, Inc. : Alexza Pharmaceuticals to Present at the 8th Annual JMP Securities Healthcare Conference	PU
25/06/13	Alexza Pharmaceuticals, Inc. : Michael S. Holfinger, PhD, Joins Alexza Pharmaceuticals as Vice President, Manufacturing & Global Supply Chain Management	PU
14/05/13	Alexza Pharmaceuticals, Inc. : Alexza Reports 2013 First Quarter Financial Results	PU